These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8597941)

  • 1. New pharmaceutical approaches to the treatment of cystic fibrosis.
    Delaney SJ; Wainwright BJ
    Nat Med; 1996 Apr; 2(4):392-3. PubMed ID: 8597941
    [No Abstract]   [Full Text] [Related]  

  • 2. Cystic fibrosis transmembrane conductance regulator biomarkers in 'real life': can we evaluate individual efficacy of cystic fibrosis transmembrane conductance regulator therapy?
    van Koningsbruggen-Rietschel S; Naehrlich L
    Ther Adv Respir Dis; 2015 Aug; 9(4):198-200. PubMed ID: 26175480
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug bests cystic-fibrosis mutation.
    Ledford H
    Nature; 2012 Feb; 482(7384):145. PubMed ID: 22318583
    [No Abstract]   [Full Text] [Related]  

  • 4. Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease.
    Perry LA; Penny-Dimri JC; Aslam AA; Lee TW; Southern KW
    Paediatr Respir Rev; 2017 Mar; 22():47-49. PubMed ID: 27964951
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacological approaches to cystic fibrosis.
    Bandiera T; Galietta LJV
    Eur J Med Chem; 2021 Apr; 216():113240. PubMed ID: 33691259
    [No Abstract]   [Full Text] [Related]  

  • 6. delta F508 in cystic fibrosis: willing but not able.
    Southern KW
    Arch Dis Child; 1997 Mar; 76(3):278-82. PubMed ID: 9135274
    [No Abstract]   [Full Text] [Related]  

  • 7. New therapies in cystic fibrosis.
    Ratjen F; Grasemann H
    Curr Pharm Des; 2012; 18(5):614-27. PubMed ID: 22229570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystic fibrosis: a multiple exocrinopathy caused by dysfunctions in a multifunctional transport protein.
    Schwiebert EM; Benos DJ; Fuller CM
    Am J Med; 1998 Jun; 104(6):576-90. PubMed ID: 9674722
    [No Abstract]   [Full Text] [Related]  

  • 9. Cystic fibrosis: CFTR modulators and their mechanism of action.
    Nieddu E
    Curr Pharm Des; 2013; 19(19):3474-5. PubMed ID: 23331031
    [No Abstract]   [Full Text] [Related]  

  • 10. Personalized medicine. New cystic fibrosis drug offers hope, at a price.
    Kaiser J
    Science; 2012 Feb; 335(6069):645. PubMed ID: 22323790
    [No Abstract]   [Full Text] [Related]  

  • 11. Cystic fibrosis as a disease of misprocessing of the cystic fibrosis transmembrane conductance regulator glycoprotein.
    Riordan JR
    Am J Hum Genet; 1999 Jun; 64(6):1499-504. PubMed ID: 10330337
    [No Abstract]   [Full Text] [Related]  

  • 12. New approaches to cystic fibrosis.
    Moss RB
    Hosp Pract (1995); 2001 Jan; 36(1):25-7, 31-2, 35-7. PubMed ID: 11197941
    [No Abstract]   [Full Text] [Related]  

  • 13. Cystic Fibrosis: The Dawn of a New Therapeutic Era.
    Heltshe SL; Cogen J; Ramos KJ; Goss CH
    Am J Respir Crit Care Med; 2017 Apr; 195(8):979-984. PubMed ID: 27710011
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical trial research in focus: ensuring new cystic fibrosis drugs fulfil their potential.
    Elborn JS; Davies J
    Lancet Respir Med; 2017 Sep; 5(9):681-683. PubMed ID: 28853396
    [No Abstract]   [Full Text] [Related]  

  • 15. A combination therapy for cystic fibrosis.
    Brodsky JL; Frizzell RA
    Cell; 2015 Sep; 163(1):17. PubMed ID: 26406363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excitement mounts for first disease-modifying cystic fibrosis drugs.
    Opar A
    Nat Rev Drug Discov; 2011 Jul; 10(7):479-80. PubMed ID: 21720393
    [No Abstract]   [Full Text] [Related]  

  • 17. Structure-function analysis of a double-mutant cystic fibrosis transmembrane conductance regulator protein occurring in disorders related to cystic fibrosis.
    Fanen P; Clain J; Labarthe R; Hulin P; Girodon E; Pagesy P; Goossens M; Edelman A
    FEBS Lett; 1999 Jun; 452(3):371-4. PubMed ID: 10386624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new phase of CFTR treatment for cystic fibrosis?
    Bell SC
    Lancet Respir Med; 2015 Sep; 3(9):662-663. PubMed ID: 26208999
    [No Abstract]   [Full Text] [Related]  

  • 19. Cystic fibrosis: five years beyond the gene.
    Porteous DJ
    J Inherit Metab Dis; 1995; 18(4):491-4. PubMed ID: 7494406
    [No Abstract]   [Full Text] [Related]  

  • 20. Correctors of the basic trafficking defect of the mutant F508del-CFTR that causes cystic fibrosis.
    Birault V; Solari R; Hanrahan J; Thomas DY
    Curr Opin Chem Biol; 2013 Jun; 17(3):353-60. PubMed ID: 23711435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.